Clinical Trial Update: Trial to Compare the Efficacy and Safety of a Single Bolus of TNK-tPA (Tenecteplase, Metalyse®) With Accelerated Infusion of Rt-PA (Alteplase, Actilyse®) in Asian Patients With Acute Myocardial Infarction [Phase 3]

View source ↗

Summary

This Phase 3 trial completed in Asian patients with acute myocardial infarction compared a single bolus of TNK-tPA (tenecteplase) to an accelerated infusion of …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Actilyse (alteplase)
• Metalyse (tenecteplase)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Myocardial Infarction | Phase 3 | Status: COMPLETED